Literature DB >> 24391080

Beneficial effects of early treatment of infantile hemangiomas with a long-pulse Alexandrite laser.

Wenting Su1, Youhui Ke, Jixin Xue.   

Abstract

BACKGROUND AND
OBJECTIVE: There is an increasing interest in treating vascular lesions with a long-pulse Alexandrite laser. However, it is difficult to search information in the literature about infantile hemangiomas (IH) treated with long-pulse Alexandrite laser. This article aims to determine whether 755 nm long-pulse Alexandrite laser is effective and safe for early intervention of IH and provides some new data on this issue.
MATERIALS AND METHODS: This is a retrospective study of 48 infants with IH treated with long-pulse Alexandrite laser during a 1.5-year period. Patients received a series of 1-7 treatment sessions with long-pulse Alexandrite laser at settings of 3 milliseconds pulse duration, 6-8 mm spot, 45-70 J/cm(2) fluences, and with dynamic cooling device (DCD) spray duration of 90 milliseconds and delay of 80 milliseconds, given at 4- to 6-week intervals.
RESULTS: This study demonstrated that IH responded favorably to the treatment of a long-pulse Alexandrite laser while accompany with relatively few complications. The difference between the original untreated and post-treatment scores of all IH and two subgroups were statistically significant, respectively (P < 0.01). The difference of the degree of improvement between the two subgroups was not significant (P > 0.05). It was observed that IH on the trunk and extremities improved more effectively and more quickly than those on the face, neck, and perineum. Besides, age at the first treatment, the sex of the patients and the presence of proliferation were not significantly correlated with the degree of improvement. Adverse effects were seen in 11 patients (22.91%): blistering (n = 9), marked edema and erosion without subsequent residual scarring (n = 1), and hypopigmentation (n = 1), which improved gradually with time. Fortunately, there was no incidence of scarring or ulceration in this case series of IH.
CONCLUSIONS: It was clinically effective and safe for early treatment of IH, including the thick/deep ones, with a long-pulse Alexandrite laser, which indicated be able to reduce the possibility that the IH will reach its full size. In this way it can prevent several complications connected to the rapid proliferation of IH.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alexandrite laser; infantile hemangiomas; therapy

Mesh:

Year:  2014        PMID: 24391080     DOI: 10.1002/lsm.22221

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  5 in total

1.  Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma.

Authors:  Jianming Wu; Fangyan Zhou; Yu Gao
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-09

2.  Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.

Authors:  Xiaohan Liu; Xinhua Qu; Jiawei Zheng; Ling Zhang
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

3.  Prospective Comparison of Dual Wavelength Long-Pulsed 755-nm Alexandrite/1,064-nm Neodymium:Yttrium-Aluminum-Garnet Laser versus 585-nm Pulsed Dye Laser Treatment for Rosacea.

Authors:  Hyun-Min Seo; Jung-In Kim; Han-Saem Kim; Young-Jun Choi; Won-Serk Kim
Journal:  Ann Dermatol       Date:  2016-09-30       Impact factor: 1.444

4.  Noteworthy effects of a long-pulse Alexandrite laser for treatment of high-risk infantile hemangioma: A case report and literature review.

Authors:  Wen-Ting Su; Ji-Xin Xue; You-Hui Ke
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

5.  Sequelae After Involution of Superficial Infantile Hemangioma: Early Intervention with 595-nm Pulsed Laser Combined with 755-nm Long-Pulsed Alexandrite Laser versus Wait-and-See.

Authors:  Ji-Cong Jiang; Qin Xu; Shan Fang; Yu Gao; Wan-Wan Jin
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.